Ohba, Takuya, Domoto, Shinichi, Tanaka, Miyu et al. · Biological & pharmaceutical bulletin · 2019 · DOI
Researchers created a mouse model of ME/CFS by repeatedly forcing mice to swim, which produced fatigue-like behaviors similar to the human condition. They found that this stress reduced the activity of an important energy-producing enzyme called PDH in muscle cells. When they treated the mice with a drug that reactivates PDH, the fatigue-like symptoms improved, suggesting this enzyme may be a target for future ME/CFS treatments.
This study provides experimental support for a specific metabolic mechanism—impaired PDH function—that may underlie ME/CFS fatigue, opening a potential new avenue for drug development. If PDH dysfunction is confirmed in human ME/CFS patients, it could justify clinical trials of PDH-activating drugs like DCA, offering hope for a targeted treatment approach for a condition that currently lacks effective therapies.
This study does not prove that PDH dysfunction causes ME/CFS in humans or that it is the primary mechanism of the disease. The forced swimming model induces acute stress-related fatigue in mice, which may differ mechanistically from human ME/CFS, which is often triggered by viral infection or other factors. The correlation between reduced PDH activity and fatigue-like behavior does not establish causation, and further research is needed to determine whether PDH activation would benefit human patients.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.